ATF3 Deficiency Promotes Genome Instability and Spontaneous Tumorigenesis in Mice

[1]  Deric M. Park,et al.  Glioma‐derived cancer stem cells are hypersensitive to proteasomal inhibition , 2017, EMBO reports.

[2]  T. Perkins,et al.  Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non–Small Cell Lung Carcinoma Cells12 , 2016, Neoplasia.

[3]  A. Gingras,et al.  The TIP60 Complex Regulates Bivalent Chromatin Recognition by 53BP1 through Direct H4K20me Binding and H2AK15 Acetylation. , 2016, Molecular cell.

[4]  Jindan Yu,et al.  The common stress responsive transcription factor ATF3 binds genomic sites enriched with p300 and H3K27ac for transcriptional regulation , 2016, BMC Genomics.

[5]  Dakang Xu,et al.  Activating Transcription Factor 3 Expression as a Marker of Response to the Histone Deacetylase Inhibitor Pracinostat , 2016, Molecular Cancer Therapeutics.

[6]  H. Ding,et al.  The Stress-responsive Gene ATF3 Mediates Dichotomous UV Responses by Regulating the Tip60 and p53 Proteins* , 2016, The Journal of Biological Chemistry.

[7]  Tsonwin Hai,et al.  Loss of ATF3 Promotes Hormone-induced Prostate Carcinogenesis and the Emergence of CK5+CK8+ Epithelial Cells , 2015, Oncogene.

[8]  W. Gu,et al.  Ferroptosis as a p53-mediated activity during tumour suppression , 2015, Nature.

[9]  H. Ding,et al.  The Stress-responsive Gene ATF3 Regulates the Histone Acetyltransferase Tip60 , 2015, Nature Communications.

[10]  Ziyan Wang,et al.  Emerging roles of ATF3 in the suppression of prostate cancer , 2015, Molecular & cellular oncology.

[11]  Tsonwin Hai,et al.  Loss of ATF3 Promotes Akt Activation and Prostate Cancer Development in a Pten Knockout Mouse Model , 2014, Oncogene.

[12]  V. Pant,et al.  Limiting the power of p53 through the ubiquitin proteasome pathway , 2014, Genes & development.

[13]  E. Li,et al.  ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma , 2014, Oncotarget.

[14]  D. Tang,et al.  The Activating Transcription Factor 3 Protein Suppresses the Oncogenic Function of Mutant p53 Proteins* , 2014, The Journal of Biological Chemistry.

[15]  Michael C. Ostrowski,et al.  Transcription factor ATF3 links host adaptive response to breast cancer metastasis. , 2013, The Journal of clinical investigation.

[16]  Dakang Xu,et al.  ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton. , 2013, Cancer research.

[17]  Chi-Ying F. Huang,et al.  Adenylate kinase-4 is a marker of poor clinical outcomes that promotes metastasis of lung cancer by downregulating the transcription factor ATF3. , 2012, Cancer research.

[18]  Wei Gu,et al.  Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence , 2012, Cell.

[19]  Y. Maehara,et al.  Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells , 2012, Oncogene.

[20]  R. Moritz,et al.  ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol–induced lipid body formation , 2012, The Journal of experimental medicine.

[21]  Tsonwin Hai,et al.  ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression , 2011, Nature Medicine.

[22]  Q. Tang,et al.  Activating Transcription Factor 3 Deficiency Promotes Cardiac Hypertrophy, Dysfunction, and Fibrosis Induced by Pressure Overload , 2011, PloS one.

[23]  Tae-Wook Kang,et al.  GENT: Gene Expression Database of Normal and Tumor Tissues , 2011, Cancer informatics.

[24]  O. Stoeltzing,et al.  Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition , 2010, BMC Cancer.

[25]  David P. Davis,et al.  Diverse somatic mutation patterns and pathway alterations in human cancers. , 2010, Nature.

[26]  Hua Lu,et al.  MDM2 Mediates Ubiquitination and Degradation of Activating Transcription Factor 3* , 2010, The Journal of Biological Chemistry.

[27]  Xing Xu.  Biogeography: Horned dinosaurs venture abroad , 2010, Nature.

[28]  K. Lefort,et al.  Calcineurin and ATF3: opposite roles in squamous skin cancer , 2010, Nature.

[29]  C. Blattner,et al.  Regulation of p53 - insights into a complex process , 2009, Critical reviews in biochemistry and molecular biology.

[30]  Lawrence A. Donehower,et al.  20 years studying p53 functions in genetically engineered mice , 2009, Nature Reviews Cancer.

[31]  Y. Surh,et al.  Expression of stress-response ATF3 is mediated by Nrf2 in astrocytes , 2009, Nucleic acids research.

[32]  Markus Löbrich,et al.  ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2 , 2009, The EMBO journal.

[33]  C. Prives,et al.  Blinded by the Light: The Growing Complexity of p53 , 2009, Cell.

[34]  T. Virolle,et al.  ATF3 and p15PAF are novel gatekeepers of genomic integrity upon UV stress , 2009, Cell Death and Differentiation.

[35]  J. Pouysségur,et al.  Hif-2alpha mediates UV-induced apoptosis through a novel ATF3-dependent death pathway , 2008, Cell Death and Differentiation.

[36]  I. Kockum,et al.  Activating transcription factor 3: a hormone responsive gene in the etiology of hypospadias. , 2008, European journal of endocrinology.

[37]  H. K. Sluss,et al.  The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression. , 2007, Cancer research.

[38]  Tsonwin Hai,et al.  A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development , 2007, Oncogene.

[39]  John Lough,et al.  Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response , 2007, Nature.

[40]  K. Robertson,et al.  Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer , 2007, Oncogene.

[41]  A. Bradley,et al.  p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Kathleen A. Kennedy,et al.  Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4 , 2006, Nature.

[43]  Y. Liu,et al.  Msh2 deficiency leads to chromosomal abnormalities, centrosome amplification, and telomere capping defect , 2006, Oncogene.

[44]  Tsonwin Hai,et al.  Activating Transcription Factor 3, a Stress-inducible Gene, Suppresses Ras-stimulated Tumorigenesis* , 2006, Journal of Biological Chemistry.

[45]  D. Boyd,et al.  ATF3 Regulates the Stability of p53: A Link to Cancer , 2006, Cell cycle.

[46]  Michael M. Murphy,et al.  53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[47]  H. Lehrach,et al.  A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome , 2005, Cell.

[48]  Tsonwin Hai,et al.  Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination , 2005, The EMBO journal.

[49]  T. Ørntoft,et al.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis , 2005, Nature.

[50]  J. Myers,et al.  Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. , 2005, Molecular cancer therapeutics.

[51]  T. Yano,et al.  Ovariectomy aggravates hypersensitivity reactions to paclitaxel in rats , 2005, Cancer biology & therapy.

[52]  Marc Prentki,et al.  Role for Activating Transcription Factor 3 in Stress-Induced β-Cell Apoptosis , 2004, Molecular and Cellular Biology.

[53]  T. Ried,et al.  H2AX Haploinsufficiency Modifies Genomic Stability and Tumor Susceptibility , 2003, Cell.

[54]  F. Alt,et al.  Histone H2AX A Dosage-Dependent Suppressor of Oncogenic Translocations and Tumors , 2003, Cell.

[55]  Mohamed Hamdi,et al.  Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2 , 2003, Oncogene.

[56]  Junjie Chen,et al.  p53 Binding Protein 53BP1 Is Required for DNA Damage Responses and Tumor Suppression in Mice , 2003, Molecular and Cellular Biology.

[57]  A. Fornace,et al.  ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth , 2002, Oncogene.

[58]  N. Tsuchida,et al.  Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53. , 2002, Biochemical and biophysical research communications.

[59]  A. Noda,et al.  Transcriptional Repressor Activating Transcription Factor 3 Protects Human Umbilical Vein Endothelial Cells from Tumor Necrosis Factor-α-induced Apoptosis through Down-regulation ofp53 Transcription* , 2002, The Journal of Biological Chemistry.

[60]  D. Boyd,et al.  ATF3 Represses 72-kDa Type IV Collagenase (MMP-2) Expression by Antagonizing p53-dependent trans-Activation of the Collagenase Promoter* , 2002, The Journal of Biological Chemistry.

[61]  S. Elledge,et al.  The DNA damage response: putting checkpoints in perspective , 2000, Nature.

[62]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[63]  T. Tsuruo,et al.  Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. , 1996, Cancer research.

[64]  Tsonwin Hai,et al.  ATF3 and ATF3 delta Zip. Transcriptional repression versus activation by alternatively spliced isoforms. , 1994, The Journal of biological chemistry.

[65]  C J Kemp,et al.  The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. , 1994, Cancer research.

[66]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[67]  L. Donehower,et al.  In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. , 1993, Oncogene.

[68]  Scott W. Lowe,et al.  p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.

[69]  C. Purdie,et al.  Thymocyte apoptosis induced by p53-dependent and independent pathways , 1993, Nature.

[70]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[71]  Tsonwin Hai,et al.  ATF3 and stress responses. , 1999, Gene expression.